Translations:Diabetes medication/30/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 12:09, 4 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Diabetes medication)
Typical reductions in [[glycated hemoglobin]] (A1C) values for second-generation sulfonylureas are 1.0–2.0%.
* First-generation agents
** [[tolbutamide]]
** [[acetohexamide]]
** [[tolazamide]]
** [[chlorpropamide]]
* Second-generation agents
** [[glipizide]]
** glyburide or [[glibenclamide]]
** [[glimepiride]]
** [[gliclazide]]
** [[glyclopyramide]]
** [[gliquidone]]

Typical reductions in glycated hemoglobin (A1C) values for second-generation sulfonylureas are 1.0–2.0%.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetes_medication/30/en&oldid=110574"